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Abstract
Background: Community acquired pneumonia (CAP) is a major cause o f  death world wide. Knowledge o f  
the likely pathogens and their sensitivity/resistance pattern can help in the choice o f  antibiotic therapy and 
improve outcome.
Objective: To identify the seasonal variation; age and sex distribution; bacteriology; antimicrobial sensitivity 
pattern o f isolates; haematological data; radiology and clinicaloutcome o f  community-acquired pneumonia 
(CAP) in adult patients admitted to hospital in Port Harcourt, Nigeria.
Design: Prospective study.
Setting: University o f  Port Harcourt Teaching Hospital, and Braithwaite Memorial Hospital, Port Harcourt, 
Rivers State.
Patients: Adults admitted to the hospitals with CAP between 1 May 2002, and 30 April 2003.
Interventions: A diagnostic strategy using regular collection o f  sputum samples for gram stain, 
bacteriological culture and chest radiography were done. Blood cultures were done in severe cases. Antibiotic 
sensitivity testing was done on the positive cultures.
Results: During a 12 month period, 54 patients aged 16 to 82 years (mean 38.1 years) were evaluated. A total 
o f944 medical admissions were seen during the same period. This gives a prevalence rate o f  5.7%. Twenty six 
classes o f bacteria were isolated from the sputum o f  23 patients (yield, 42.6%). Streptococcus pneumoniae, 
the most common pathogen, was isolated in nine cases (34.6%), followed by Klebsiella pneumoniae which 
was present in eight (30.8%). Other isolates included, Escherichia coli, four cases (15.4%), Pseudomonas 
aeruginosa, three cases (11.5%), and Staphylococcus aureus, two cases (7.7%). The commonest radiological 
pattern was lobar consolidation (49.9%) with no Distinct pattern associated with any conventional bacterial 
pathogen. The isolates showed good sensitivity to the newer and more expensive antibiotics (quinolines and 
cephalosporines) with marked resistance to the older and cheaper ones. However, clinical responses to benzyl 
penicillin and gentamycin were found to be good. Out o f  54 patients evaluated, four (7.4%) died.
Conclusion: Streptococcus pneumoniae and Klebsiella were common aetiological organisms o f  CAP in Port 
Harcourt. Treatment o f  CAP with benzyl penicillin remains an appropriate first line choice in this 
environment while the more expensive quinolines and cephalosporines can be used as backups.
Introduction
Community-acquired pneumonia (CAP) remains a 
leading cause of death in both developing and 
developed countries. Furthermore it may continue to 
represent an important threat to patients in future as the
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number of patients at risk (elderly people and those 
with comorbid conditions) increase.' Estimates of 
annual incidence vary between 1% and 12%.2 In the 
USA, four million episodes are reported annually, with 
64 million days of restricted activity, 39 million days of 
bed confinement and 10 million days of work loss, with
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billions on dollars spent annually caring for the 
patients.1 Though data on prevalence-based burden of 
illness study is lacking in Africa, the situation may not 
be different.
The World Health Organization (WHO) estimates 
that respiratory tract infections in general are 
responsible for more than four million deaths 
worldwide each year with over one million occurring 
in sub-Saharan Africa.3 In six black African countries, 
pneumonias were the commonest respiratory disease 
requiring medical admissions.4
Community and hospital based studies have 
identified bacteria as the predominant cause of 
pneumonia in adults with Streptococcus pneumoniae 
being responsible in as many as two third cases. Other 
common causative organisms are Haemophilus 
influenzae; Mycoplasma pneumoniae; Staphylococcus 
aureus; S treptococcus pyogenes; N eisseria  
meningitides and other gram-rifegative rods.
The therapeutic treatment of these respiratory 
infections has continued to present serious medical and 
public health problems because of the ease with which 
these organisms acquire resistance to antibiotics.1,2 At 
the same time, early institution of antimicrobial 
therapy is associated with improvement in morbidity 
and mortality.6 It is therefore necessary to identify the 
common causative organisms of CAP in ones locality 
and identify their antimicrobial susceptibility as this 
will be a major guide to early management, especially 
in health centres in rural areas and private clinics where 
facilities for proper investigation are non-existent.
In Port Harcourt, the capital of Rivers State which is 
a major city in a densely populated Niger Delta region, 
there are no published studies on the aetiology of CAP 
and the possible first line antibiotic susceptibility. This 
study was, therefore, undertaken for that purpose.
M aterials and M ethods
This study was carried out at the University of Port 
Harcourt Teaching Hospital (UPTH), a tertiary Federal 
institution and the Braithwaite Memorial Specialist 
Hospital (BMH) owned by the Rivers State 
Government. Both hospitals are located in Port 
Harcourt, and serve as referral hospitals for Rivers 
State and other adjoining states of the Niger Delta 
region which include Bayelsa, Delta, Abia, Imo and 
Akwa Ibom. Ethical approval for the study was 
obtained from the ethics committees of the two 
hospitals. Informed consent was obtained from the 
patients.
All patients aged 15 years and above admitted into 
the casualty wards and the medical wards of UPTH and 
BMH with a provisional diagnosis of pneumonia 
between 1 May 2002 and 30 April 2003 were evaluated 
for inclusion. Symptoms would have been present for 
not more than 14 days prior to presentation and should 
consist of at least two of the respiratory symptoms of 
cough with or w ithout sputum production;
breathlessness; chest pain; haemoptosis and fever. In 
addition, there should be radiological evidence of 
consolidation on posterior-anterior and/or lateral chest 
radiograph.
Patients whose illness had lasted for more than 14 
days or those who developed pneumonia while on 
admission in the medical wards for some other 
condition or who refused to give consent were 
excluded. Cases of chronic obstructive pulmonary 
disease (COPD), pulmonary tuberculosis or human 
immunodeficiency virus (HIV) infection were also 
excluded.
Patients with productive cough were asked to 
produce the sputum samples in the mornings, before 
meals, or not less than one hour after their last meal and 
after rinsing the mouth with water.
Sputum cultures were done on blood agar, chocolate 
agar and MacConkey agar and incubated aerobically at 
37° C for 18 to 24 hours. Sensitivity testing was done 
using disc diffusion methods with commonly available 
antibiotics. Following overnight incubation, the 
culture was examined for areas of no growth around the 
discs (zone of inhibition). The antimicrobial sensitivity 
pattern for the different bacterial isolates were 
documented.
Patients adjudged to have severe disease at 
presentation respiratory rate more than 30/min, 
confusion, hypotension and multilobar involvement on 
chest radiograph, had two 10ml of venous blood 
withdrawn from two different venopuncture sites for 
blood culture, in addition to sputum examination. Such 
samples were collected within 24 hours of presentation 
and cultured aerobically in thioglycollate broth and 
anaerobically in typticase soy broth for seven days.
Patients with pleural effusion demonstrated 
clinically and or radiological ly had percutaneous trans­
thoracic pleural aspiration done using 21G needle. The 
aspirate was sent for microscopy (Gram's stain) and 
was cultured on blood, Mac Conkey and agar plates.
All patients at presentation had 5mls of blood 
obtained for full blood count and erythrocyte 
sedimentation rate estimation.
Statistical Methods: All data obtained were entered 
into a prepared questionnaire and analyzed using the 
statistical package, Epi-Info version 6, produced by the 
WHO in collaboration with the Centre for Diseases 
Control and Prevention. Mean, standard deviation, 
analysis of variance, tables and figures were used 
where appropriate.
Results
Fifty four episodes of confirmed community-acquired 
pneumonia were studied. One patient was admitted 
twice in the course of the study, with each episode 
treated independently. A total of 944 medical 
admissions were seen during the period. This gives a 
prevalence rate of 5.7%.
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Month of Presentation.
The highest number of monthly admission was noticed 
in March, with 10 cases (18.5%) seen. The least 
number of admissions were in the months of September 
and December one case each. No admission was 
recorded for the month of November. Thirty eight of 
the admissions were between February and June 
(70.4%). Table I shows the months of presentation.
Table I: Cases o f  CAP according to month 
presentation.
Month of Presentation No. of Cases (%)
January 2(3.7)
February 7(912.9)
March 10(18.5)
April 8(14.8)
May 5(14.8)
June 3 (9.2)
July 5(5.5)
August 5(9.2)
September 1(1.8)
October 4(7.4)
December 1(1.9)
Total 54
Age and Sex.
The age of the patients ranged from 16 to 82 years with
ameanof38.1 (SD. 17.62) years. The peak age groups
were 20 to 29 years.(42.6%).
There were 30 males (55.6%) and 24 females (44.4%),
giving a male: female ratio of 1.3:1.
Table II shows the age and sex distribution of the
patients.
Table II: Age-sex distribution o f  patients.
Age Group Males Females Total (%)
(Years)
10-19 2 3 7(12.9)
20-29 13 10 10(18.5)
30-39 2 2 8(14.8)
40-49 5 2 5(14.8)
50-59 3 2 3(9.2)
60-69 4 3 5(5.5)
70-79 1 1 5(9.2)
80-89 0 1 1(1.8)
Total 30(55.6%) 24(44.4%) 54
Haematology.
Twenty one patients (38.9%) had haemoglobin 
concentration in the range of 10 to 11.9 gm/dl while 24 
patients (44.5%) and nine patients (16.6%) had 
haemoglobin concentrations less than 10 g/dl and 
above 12 g/dl respectively. The mean haemoglobin 
concentration for females was 9.1 g/dl (SD 1.64) with a 
range of 6.5 to 13 g/dl and for males; the mean 
concentration was 11.2 g/dl (SD 2.03) with a range of 
7.6 to 16 g/dl. There was significant difference in the 
haemoglobin values of males and females (p 
value=0.0015).
Table III shows the haemoglobin profile of the 
patients.
Table III: Haemoglobin profile ofthe patients.
Hb (gm/dl) Males Females Total (%)
6.5-7.9 1 6 7(12.9)
8.0-9.9 6 11 17(31.6)
10-11.9 16 5 21(38.9)
12-13.9 5 2 7(12.9)
>14 2 0 2(3.7)
Total 30 24 54
The mean total white cell count of the patients was 8.5 x 
109/L (SD 3,8 x 109'1) with a range of 2.2 to 16.7 x 109/L. 
The mean neutrophil count was 66.7% (SD 14.8) with a 
range of 24 to 90%, while the mean lymphocyte count 
was 32.8% (SD 14) with a range of 10 to 72%.
The mean erythrocyte sedimentation rate obtained for 
50 patients was 64.6mm/hr (SD 50.3). The results of 
four patients could not be traced.
Table IV showed the distribution of the total white 
cell count.
Table IV: Distribution o f total white cell count (wbc).
wbc(xlO’) Total (%)
2-3.9 6(11.2)
4-11.0 38(70.3)
11.1-18.0 10(18.5)
Total 54
Radiology.
Chest radiograph done at presentation showed that 27 
patients (49.9%) had lobar consolidation, 10 (18.5%) 
had multiple lobes involvement and 17 (31.6%) had 
patchy (bronchopneumonic) consolidation.
Table V shows the frequency of the radiographic 
consolidations.
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Table V: Radiological in the patients.
Radiographic
consolidation
No. of Cases (%)
Lobar 27 (50%)
Multiple lobes 10(18.5)
Patchy 17(31.5)
Total 54 (100)
Bacteriology.
Sputum culture specimens were obtained in the 54 
patients evaluated. Of the 54 patients, 31 (57.4%) had 
no identifiable microbial agent isolated. In the 23 
patients with identifiable pathogens, Strep, 
pneumoniae was the predominant pathogen isolated 
(34.6%). Three of these patients had mixed infection,
with Strep, pneumoniae and Klebsiella pneumoniae 
isolated in two patients, and Strep, pneumoniae and P. 
aeruginosa isolated in one patient.
Table VI shows the organisms isolated from sputum, 
including mixed infection.
Table VI: Organisms cultured from the sputum o f  
patients.
Organisms cultured No. of isolates (%)
S. pneumoniae 9 (34.6)
K. pneumoniae 8 (30.8)
E. coli 4 (15.4)
Pseudomonas aeruginosa 3(11.5)
S. aureus 2 (7.7)
Total 26 (100)
Table VII: Antimicrobial susceptibility pattern o f  the individual bacterial isolates (including mixed infections).
Bacterial
isolates
No. of 
strains 
tested
Cipro Amp Strep Clox Amy Amc Cefz Ceft Chlo Ery Gen Oflo Pen Pet Tet Cot Cef
E. Coli 4 3(75) 0 2(50) 1(25) 0 0 3 (75) 3 (75) 0 2(50) 4(400) 3(75) 0 1 (25) 1(25) 1(25) 2(50)
K. Pneumoniae 8 6(75) 1 (12.5) 2(25)' 2(12.5) 0 3 (37.5) 4 (50) 4(50) 2(25) 2(25) 7 (87.5) 5 (62.5) 0 2(25) 2(25) 0 7 (87.5)
P,! Aeruginosa 3 3(100) 0 1 (33.3) 0 0 1 (33.3) 1 (33.3) 3 (100) 0 0 3(100) 3 (100) 0 0 0 0 1 (33.3)
S. Peumoniae 9 1 (11.1) 3(33.3) 0 2 (22.2) 3 (33.3) 4(44.4) 5 (55.6) 5 (55.6) 6 (66.7 6 (66.7) 2 (22.2) 8 (88.9) 3 (33.3) 1 (11.1) 1 (II .1) 0 8 (88.9)
S, Aureus 2 1(50) 0 0 1(50) 0 2(100) 2(100) 2 (100) 1 (50) 2(100) 0 1 (50) 0 0 0 0 1(50)
Kevs
Cipro - Ciprofloxacin Clox - Cloxacillin Cefz - Ceftzidime
Amp -Ampicilin Amx -Amoxyllin Ceft - Ceftriaxone
Strep • Streptomycin Amc • Amoxyllin/ Chlo- Chloramphenicol
Clavulanate
All the four isolates (100%) of E. Coli were sensitive to 
gentamycin (Table VII), 3 (75%) to ciprofloxacin, 
ceftazidime, ceftriaxone and ofloxacin, two (50%) to 
cefuroxime and streptomycin. A single isolate was 
sensitive to pefloxacin, tetracycline, co-trimoxazole 
and cloxacillin. There were no isolates sensitive to 
ampicillin, amoxicillin, amoxicillin/clavulanate, 
chloramphenicol and penicillin G.
Seven (87.5%) of the eight isolates of Klebsiella 
pneumoniae were sensitive to gentamycin and 
cefuroxime, six (75%) to ciprofloxacin, five (62.5%) to 
ofloxacin, and four (50%) to ceftazimide. Two isolates 
were sensitive to streptomycin, chloramphenicol, 
erythromycin, pefloxacin and tetracycline, while one 
isolate was sensitive to ampicillin and cloxacillin. All 
isolates were resistant to amoxicillin/Clavulanate. For 
P. aeruginosa, all three isolates were sensitive to 
ciprofloxacin, ceftriaxone, gentamycin and ofloxacin, 
with no isolate sensitive to ampicillin, cloxacillin, 
am oxicillin, chloram phenicol, erythrom ycin, 
p en ic illin  G, pefloxacin , te tracy c lin e  and 
cotrimoxazole.
Ery - Erythromycin Pen - Penicillin Cot - Cotrimoxazole
Gen - Gentamycin Pef • Pefloxacin Cef • Cefuroxime
Oflo • Ofloxacin Tet - Tetracycline
Out of the nine isolates of Strep. Pneumoniae tested, 
eight (88.9%) were sensitive to cefuroxime and 
o floxac in , six (66 .7% ) w ere sen sitiv e  to 
chloramphenicol and erythromycin and five (55.6%) to 
ceftriaxone and ceftazimide. All were resistant to 
amoxicillin/clavulanate, amoxicillin, ampicillin, 
penicillin G, cloxacillin, gentamycin, ciprofloxacin, 
p e flo x ac in , te trac y c lin e  strep to m y cin  and 
cotrimoxazole.
All two isolates of Staphylococcus aureus were 
sensitive to amoxicillin-clavulanate, ceftazidime, 
ceftriaxone and erythromycin. A single isolate was 
s e n s i t iv e  to  c ip r o f lo x a c in ,  c lo x a c i l l in ,  
chloramphenicol, ofloxacin and cefuroxime. No 
isolate was sensitive to ampicillin, streptomycin, 
amoxicillin, gentamycin, penicillin G, pefloxacin, 
tetracycline and co-trimoxazole.
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Table VIII: Susceptibility o f  the total (26%) bacterial 
isolates to the individual anti microbial agents.
Antimicrobial
agents
No. o f sensitive 
isolates %
Ofloxacin 20 (77)
Cefuroxime 19(73.2)
Ceftriaxone 16(61.6)
Gentamycin 16(61.6)
Ceftazimide 15(57.8)
Ciprofloxacin 14 (53.8)
Erythomycin 12(46.2)
Amoxicillin/Clavulanate 10(38.5)
Chloramphenicol 9 (38.5)
Streptomycin 5(19.3)
Ampicilin * 4(15.4)
Cloxacillin 4(15.4)
Tetracycline 4(15.4)
Amoxillin 3(11.6)
Penicillin 3(11.6)
Pefloxacin 3(11.6)
Cotrimoxazole ; 1 (3.9)
Combining the results of the antimicrobial sensitivity 
of the 26 bacterial isolates tested showed that 20 (77%) 
of the isolates were sensitive to ofloxacin; 19 (73.2%) 
to cefuroxime; 16 (61.6%) to ceftriaxone and 
gentamycin; 15 (57.8%) to ceftazidime; 14 (53.8%) to 
ciprofloxacin (Table VIII). Only one isolate (3.9%) 
showed sensitivity to co-trimoxazole with three 
(11.6%) sensitive to penicillin G, amoxicillin, 
pefloxacin, four (15.4%) to ampicillin, cloxacillin, 
tetracycline, five (19.3%) to streptomycin, nine 
(38.5%) to chloramphenicol and 10 (34.7%) to 
amoxicillin/clavulanate.
None of the blood cultures isolated any pathogens 
after seven days of incubation.
There were eleven (20.4%) patients with pleural 
effusions (one empyema and 10 serous effusions). No 
pathogen was isolated from the culture of the effusions.
Clinical Outcome
All patients at presentation were started empirically on 
Benzylpenicillin. Those who did not show clinical 
improvement after 72 hours were changed to another 
antimicrobial agent, based on the result of the sputum 
examination. Of the 54 patients seen in this study, one 
absconded, four (7.4%) died, 40 (74.1%) were well and 
were discharged, while nine (16.7%) were still 
symptomatic three weeks after admission. Table IX.
Table IX: Clinical outcome three weeks following 
admission.
Outcome No. of patients (%)
Absconded 1 (1.8)
Died 4(7.4)
Discharged 40 (74.1)
Still symptomatic 9(16.7)
Total 54
Discussion
The admission rate of patients in the study was twice as 
high at the end of the dry season as in the middle of the 
rainy season. This seasonal variation is similar to that 
reported in Zambia7 and Ethiopia8 but slightly different 
from that reported in Northern Nigeria9'10 where most of 
the patients were present during the dry season and the 
dusty cold harmattan period between October and 
February. This difference between the north and south 
of this country may probably be due to the different 
climate of those areas.
Pneumonia is a disease of young adults in sub- 
saharan Africa as was also noted in this study where the 
peak age group was 20 to 29 years (42.6%). 
Additionally, increasing number of cases were seen in 
those over 60 years of age (19%), a possible reflection 
of the co-existing illnesses (comobidity) such as 
diabetes mellitus, renal insufficiency, congestive heart 
failure and chronic liver disease prevalent in that age 
group and known to be risk factors for pneumonia. It is 
possible that in the near future pneumonia will become 
a disease of the elderly in this environment, as in the 
western, industrialized countries.
There are variable proportions of patients in which 
the cause of pneumonia is identified. This ranges from 
16.5% to 98% depending on the diagnostic specificity 
of the method used. In this study, pathogens were 
identified in 23 (42.6%) patients. Strep, pneumoniae 
remained the predominant pathogen in this study, as in 
other studies, though the incidence is somewhat lower. 
This may be due to prior anti-microbial use. It has also 
been reported that most of those cases of unknown 
aetiology may actually be due to Strep, pneumoniae.'1 
Gram-negative pathogens were found to be the most 
common group responsible for pneumonia in this 
study, as was reported decades earlier by Sofowora and 
Onadeko in South West Nigeria.12 Gram-negative 
pathogens as causes of pneumonia had been associated 
with certain risk factors: severe disease; comorbid 
respiratory disorders; prior antimicrobial therapy and 
use of sputum examination.13'14 It had been established 
that when sputum examination is used in determining 
aetiology of pneumonia, gram-negative pathogens are 
reported in excess, as mixed pathogens, even when 
lung aspirate culture from the same patients yielded 
only a single pathogen.15 This may account for the high
Cent AfrJM ed  2008;54(l/4) 5
number of gram-negative pathogens isolated in this 
study that utilized sputum examination. Some workers, 
however, did not report similar findings using sputum 
examination.5-9 Comorbid respiratory disorders, 
debilitation, alcoholism and intravenous drug abuse 
have also been associated with gram-negative 
pathogens. Gram-negative pathogens especially 
Klebsiella pneumoniae are isolated predominantly in 
healthy young adults in Africa unlike the western 
countries." Prior antimicrobial therapy as a risk factor 
for the development of pneumonia due to gram­
negative pathogens has been reported.6-16 In this study 
about 59% of the patients admitted to prior antibiotic 
usage before presentation which is within the range of 
35 to 88% reported in other studies in Nigeria and 
Africa.9 7 Haemophilus influenzae was not isolated as a 
cause of pneumonia, even though it is ranked among 
the top five common aetiologies of CAP worldwide.17 
Earlier studies had indeed shown that Haemophilus 
influenzae is not commonly isolated in patients with 
CAP in this environment.912 This may be due to prior 
antibiotic therapy, as earlier suggested, before 
admission or to the fastidious nature of the organism 
such that it is easily overgrown by other pathogens in 
sputum culture, especially if there is a delay in sample 
processing of more than four hours. Staph, aureus was 
isolated in two (3.7%) cases, which is similar to the 3 to 
10% formed in other studies.18'19 Staph, aureus is 
usually associated with severe disease, as was found in 
this study.
An interesting finding in this study is the resistance 
of the isolates to the older and commonly used 
antibiotics in this environment. The common first-line 
antibiotics in many health care facilities in sub-Saharan 
Africa are ampicillin; chloramphenicol; erythromycin; 
gentamycin; penicillin; tetracycline and co- 
trimoxazole. However, available second-line drugs 
vary within localities but often include amikacin; 
amoxicillin/clavulanaie; cefuroxime; ciprofloxacin 
and nalidixic acid/0 This resistance to first-line 
antibiotics had shown increasing prevalence in the last 
15 years.
What makes this finding troubling is the increased 
resistance o f the isolates to pefloxacin, a 
fluoroquinolone and second-line drug. While there is 
accum ulating evidence o f  the efficacy  o f 
fluoroquinolones in the treatment of pneumonia,18 
treatment failures have already been reported with 
fluoroquinolones.22 The resistance of most isolates to 
pefloxacin, and Strep, pneumoniae to ciprofloxacin 
may be a reflection of the general abuses of these drugs 
in the treatment of febrile illnesses wrongly attributed 
to “typhoid” in this environment. Ikeh in Jos also 
reported that while 85% of methicillin resistant Staph, 
aureus were sensitive to ofloxacin, only 45% were 
sensitive to pefloxacin.23 This resistance may extend to 
other fluoroquinolones if no effective drug policy is put 
in place, as these drugs are increasingly being marketed 
in their generic forms and as a result become cheaper 
and affordable.
The beta-lactamase inhibitory property of clavulanate 
in amoxicillin/clavulanate could explain its better 
potency compared to the other penicillins as was 
observed in this study.
Erythromycin, a macrolide, is not effective against 
Klebsiella and Pseudomonas, but has good activity 
against the other pathogens.
The implication is that erythromycin should not be 
given empirically as monotherapy in patients admitted 
for pneumonia except where it is established that 
Staphylococcus pneumoniae is the causative pathogen.
Combining results of susceptibility testing showed 
increased sensitivity of the isolates to fluoroquinolones 
(except pefloxacin), cephalosporins and gentamycin, 
which is a reflection of the high number of gram­
negative pathogens isolated in this study. Gram­
negative pathogens (Eneterobacteriaceae and 
Pseudomonas aeruginosa) have been shown to have 
high su scep tib ility  to the cephalosporins, 
fluoroquinolones and aminoglycosides.1-614 These 
drugs, except gentamycin, are expensive and may not 
be readily available in some of our rural communities, 
making their use as first line therapy for pneumonia 
difficult to implement in rural areas.
All the patients in this study were all started on 
benzylpenicillin, with most of them improving on it 
despite the in vitro resistance of most of the isolates to 
penicillin. This shows that in vitro resistance does not 
translate to in vivo resistance as previously 
documented.24-23 Studies have shown that strains of 
Strep Pneumoniae in sub-Saharan Africa do not show 
full resistance to benzylpenicillin, and that response to 
benzylpenicillin could still be obtained if  high doses 
are adm in istered .5-7-9 Treatm ent failure with 
benzyllpenicillin had been attributed to the presence of 
other pathogens.5-25-26
Not all patients in this study were able to mount 
leucocyte responses to pneumonia, 
which raises the question of whether the probably 
widespread suboptimal nutrition in this environment is 
an important factor in predisposing people to 
pneumonia and blunting the immune response to 
infection. Further studies on the relationship between 
nutritional state, immune response, and bacterial 
infection would help clarify the picture and provide a 
factual basis on which to plan effective primary health 
care schemes aimed at reducing the incidence of 
bacterial pneumonia.
The radiological abnormalities of patients in this 
study are not different from earlier studies, with lobar 
consolidation being the predominant finding.5 7-9 No 
distinct radiographic pattern could be ascribed to any 
conventioned bacterial pathogen. Pleural effusion as a 
complication of pneumonia was observed in 20.4% of 
the patients in this study. Other workers in Nigeria, 
Guinea and Ethiopia have reported values of 14 to 
22.7%. 8-12 26 However, the radiographic abnormalities 
of the patients show that patients whose pneumonias 
were due to E. Coli, Pseudomonas aeruginosa and 
Staphylococcus aureus presented predominantly with
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lobar consolidation, similar to those with unknown 
aetiology. Klebsiella pneumoniae patients had 
predominantly patchy consolidation while the two 
cases attributed to Staphylococcus aureus presented 
with multiple lobe consolidation. Findings were, 
however, not statistically significant (p=0.164).
The mortality of hospital-treated pneumonia in 
African series is 5 to 23%,67and is consistent with the 
finding in the study with a mortality of 7.4%. It is also 
similar to that of more developed countries, but with 
younger adults dying than the elderly.
Conclusion
This study demonstrates that pneumonia is common at 
the end of the dry season. It occurs mainly in young 
adults. Streptococcus pneumoniae is the most common 
pathogen responsible for CAP, while gram-negative 
bacilli (Enterobacteriaceae and Pseudomonas 
aeruginosa) form the com m onest group of 
conven tional b ac te ria  iso la ted . Increasing  
indiscriminate use of broad spectrum antibiotic in the 
community may be responsible for the high number of 
cases in which no aetiologic pathogens were isolated.
While in vitro resistance of the isolates was 
demonstrated against the older and cheaper antibiotics 
(except gentamycin), with increased susceptibility to 
the newer and more expensive drugs (cephalosporins 
and flu o q u in o lin e s), in vivo  response  to 
benzylpenicillin was found to be very good in most of 
the patients. This confirms that benzyl penicillin is still 
a relevant first line drug in the management of 
pneumonia in this environment.
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